MedicalResearch.com Interview with: Nathan A. Berger, M.D. Distinguished University Professor
Hanna-Payne Professor of Experimental Medicine
Professor of Medicine, Biochemistry, Oncology and Genetics
Director, Center for Science, Health and Society
Case Western Reserve University School of Medicine   Rong Xu, PhD Professor, Biomedical Informatics Director, Center for Artificial Intelligence in Drug Discovery Case Western Reserve University School of Medicine     MedicalResearch.com: What is the background for this study? Response: 75% of the US Population has overweight or obesity and 15% has Type 2 Diabetes. Both overweight/obesity and diabetes promote increased incidence and worse prognosis of colorectal cancer. The new GLP1RA drug class are rapidly becoming the most effective treatment for both diabetes and overweight/obesity. By controlling diabetes and overweight/obesity, we hypothesized that the GLP1RAs might be effective at reducing incidence of colorectal cancer. (more…)